Clinical Trial Update: Safety and Efficacy Assessment of Autologous Bone-marrow Derived Adult Mesenchymal Stem Cell Therapy in Patients With Anoxic(or Hypoxic) Brain Injury Pilot Trial [NA]

View source ↗

Summary

This clinical trial update discusses the safety and potential efficacy of using autologous bone marrow-derived mesenchymal stem cells to treat anoxic or hypoxic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anoxic Brain Injury
• Hypoxic Brain Injury

Drugs mentioned

• Autologous bone marrow-derived mesenchymal stem cell therapy

Snippet

Sponsor: Hyun Young Kim | Conditions: Anoxic Brain Injury | NA | Status: UNKNOWN